Insomnia

Showing NaN - NaN of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD, Insomnia Trial in United States (SAGE-217, Placebo)

Terminated
  • Major Depressive Disorder
  • Insomnia
  • Little Rock, Arkansas
  • +27 more
Oct 13, 2022

Insomnia Trial in United States (Daridorexant 10 mg, Daridorexant 25 mg, Daridorexant 50 mg)

Recruiting
  • Insomnia
  • Daridorexant 10 mg
  • +3 more
  • Little Rock, Arkansas
  • +11 more
Aug 15, 2022

Insomnia Trial in United States (V117957 tablets, Placebo)

Completed
  • Insomnia
  • V117957 tablets
  • Placebo
  • Glendale, California
  • +16 more
Jul 27, 2021

Insomnia Trial in United States (LEM 5 mg, LEM 10 mg)

Completed
  • Insomnia
  • LEM 5 mg
  • LEM 10 mg
  • Glendale, Arizona
  • +16 more
Mar 17, 2021

Depression, MDD, MDD Trial in Atlanta, Augusta (suvorexant, Placebo)

Unknown status
  • Depression
  • +3 more
  • Atlanta, Georgia
  • +1 more
Feb 25, 2019

Insomnia, Sleeplessness, Transient Insomnia Trial in United States (Electric stimulation of the Vestibular Nerve - "VirtuSom",

Completed
  • Insomnia
  • +2 more
  • Electric stimulation of the Vestibular Nerve - "VirtuSom"
  • Electric stim of the Vestibular Nerve - "VirtuSom" - SHAM
  • Atlanta, Georgia
  • +5 more
Dec 13, 2018

Insomnia, ADHD Trial in United States (eszopiclone)

Completed
  • Insomnia
  • Attention Deficit Hyperactivity Disorder
  • Tucson, Arizona
  • +88 more
Sep 25, 2017

Hypertension, Prehypertension, Insomnia Trial in Atlanta (Cognitive Behavioral Therapy, Healthy Sleep Habits)

Completed
  • Hypertension
  • +2 more
  • Cognitive Behavioral Therapy
  • Healthy Sleep Habits
  • Atlanta, Georgia
    Emory University
Aug 29, 2016

Insomnia, HIV, Aids Trial in Atlanta (CBT-I Treatment Condition, SH Comparison Condition)

Completed
  • Insomnia
  • +2 more
  • CBT-I Treatment Condition
  • SH Comparison Condition
  • Atlanta, Georgia
    Grady Memorial Hospital/Infectious Disease Program
May 5, 2016

Insomnia Trial in United States (Eszopiclone, Placebo)

Completed
  • Insomnia
  • Birmingham, Alabama
  • +81 more
Feb 12, 2016

Insomnia Trial in Atlanta, New York, Cincinnati (NBI-34060)

Withdrawn
  • Insomnia
  • Atlanta, Georgia
  • +3 more
Apr 23, 2015

Sleep Initiation and Maintenance Disorders, Insomnia Trial in Canada, United States (GW679769)

Completed
  • Sleep Initiation and Maintenance Disorders
  • Insomnia
  • Birmingham, Alabama
  • +70 more
Apr 14, 2015

Insomnia Trial in United States (20 mg VEC-162, 50 mg VEC-162, 100 mg VEC-162)

Completed
  • Insomnia
  • 20 mg VEC-162
  • +3 more
  • Birmingham, Alabama
  • +18 more
Oct 8, 2014

Insomnia, ADHD Trial in United States (eszopiclone, Placebo)

Completed
  • Insomnia
  • Attention Deficit Hyperactivity Disorder
  • Birmingham, Alabama
  • +72 more
Jun 7, 2013

Insomnia Trial in Canada, United States (PD 0200390, Placebo)

Completed
  • Insomnia
  • PD 0200390
  • Placebo
  • Birmingham, Alabama
  • +83 more
Jul 17, 2012

Insomnia, Generalized Anxiety Disorder Trial in United States (Eszopiclone (Lunesta))

Completed
  • Insomnia
  • Generalized Anxiety Disorder
  • Eszopiclone (Lunesta)
  • Birmingham, Alabama
  • +63 more
Feb 21, 2012

Insomnia Trial in United States (Eszopiclone, Placebo)

Completed
  • Insomnia
  • Mobile, Alabama
  • +50 more
Feb 21, 2012

Insomnia, Depressive Disorder, Major Trial in United States (Eszopiclone, Placebo)

Completed
  • Insomnia
  • Depressive Disorder, Major
  • Birmingham, Alabama
  • +64 more
Feb 21, 2012

Insomnia, Parkinson's Disease Trial in Atlanta (valerian)

Completed
  • Insomnia
  • Parkinson's Disease
  • Atlanta, Georgia
    Emory University Medical School/Wesley Woods Hospital
Jul 25, 2006